ADVANCED PHARMACOLOGY FOR
c c cc
PRESCRIBERS 1ST EDITION BY LUO K
c c c c c
AYINGO TEST BANK | 2024 UPDATE
c c c c c
, Table of Contents
c c
Chapterc 1:cAncIntroductionctocEvidence-BasedcClinicalc PracticecGuidelines ................................................ 3
Chapterc 2:cPharmacokineticsc /Chapter3:c Pharmacodynamics...................................................................... 13
Chapter4:cPharmacogeneticsc andcPharmacogenomics ................................................................................. 25
Chapterc 5:cPharmacologyc Acrossc thecLifecSpan .......................................................................................... 30
Chapterc 6:cDrug-TherapycPrescribingcincSpecialcPopulations...................................................................... 36
Chapterc 7:cDrugcDevelopmentc andcApproval .............................................................................................. 45
Chapterc8-Chapterc10:cFoundationscofcPrescriptioncWritingcChapterc9:cResponsibleControlled-
SubstancecPrescribingcChapterc10:cAntibioticcStewardship.......................................................................... 51
Chapterc 11:c AppliedcCalculationsc forc Prescribing ....................................................................................... 58
Chapterc12-:cPromotingcAdherencecWithcPharmacotherapycII:cSystem-SpecificcandcPatient-
FocusedcPrescribingcChapterc13:cPharmacotherapycforcEar,cNose,cMouth,candThroatcConditionsc/Chapterc1
4:cPharmacotherapycforcEyecConditions....................................................................................................... 67
Chapterc 15:cPharmacotherapycforc Skinc Conditions ..................................................................................... 74
Chapterc 16:cPharmacotherapycforc Neurologicc Conditions ........................................................................... 81
Chapterc 17:cPharmacotherapycforc Cardiovascularc Conditions .................................................................... 94
Chapterc 18:cPharmacotherapycforc RespiratorycConditions ........................................................................ 106
Chapterc19:cPharmacotherapycforcGastrointestinalcConditionscandcConditionscRequiringNutritionalcSupport
................................................................................................................................................................... 117
Chapterc 20:cPharmacotherapycforc GenitourinarycConditions..................................................................... 128
Chapterc 21:cPharmacotherapycforc Renal,cAcid–Base,c Fluid,candcElectrolytecDisorders ............................ 133
Chapterc 22:cPharmacotherapycforc MusculoskeletalcandcRheumatologicc Conditions................................. 146
Chapterc 23:cTherapeuticc Applicationsc ofc Immunologyc andc Vaccines ....................................................... 158
Chapterc 24:cPharmacotherapycforc EndocrinecDisorders ............................................................................ 163
Chapterc25:cPharmacotherapycforcHematologicc Disorders ........................................................................ 174
Chapterc 26:cHematology/OncologycandcSupportivec Carecforc thecNononcologist ...................................... 190
Chapterc 27:cPharmacotherapyc RelatedctocWomen’sc Healthc Conditions .................................................... 196
Chapterc 28:cPharmacotherapycRelatedctocMen’sc Healthc Conditions.......................................................... 211
Chapterc 29:cPharmacotherapyc Relatedc tocTransgenderc Care ..................................................................... 217
Chapterc 30:cAntimicrobialcPharmacotherapy............................................................................................. 224
Chapterc 31:cAntiretroviralcPharmacotherapy ............................................................................................. 235
Chapterc32:cPsychopharmacologycandcIntegrativecHealth:cCombinedcTreatmentcofPsychiatriccandcNeuroco
gnitivec Conditions ...................................................................................................................................... 247
Chapterc 33:cPharmacotherapycforc PaincManagement ................................................................................ 257
Chapterc 34:cSubstancecUsecDisorderc III:cHealthcPromotioncandcMaintenance .......................................... 267
Chapterc 35:cOver-the-Counterc Medications............................................................................................... 283
Chapterc36:cPharmacotherapycforc Obesity ................................................................................................. 291
,Chapterc1:cAncIntroductionc tocEvidence-BasedcClinicalcPracticecGuidelines
MULTIPLEcCHOICE
• Whatciscthecprimaryc purposec ofcthec nursingc assessment?
A. Identifyingc underlyingc pathologicc conditions
B. Assistingc thec physicianc incidentifyingc medicalc conditions
C. Determiningc thec patientscmentalcstatus
D. Exploringc patientc responsesc toc healthc problems
ANS:cD
Acnursingcassessmentciscdonectocidentifycthecpatientscresponsectochealthcprob
lems.cDuringcthecnursingcassessmentcphase,caccomprehensivecinformationcba
seciscdevelopedcthroughcacphysicalcexamination,cnursingchistory,cmedicationc
history,candcprofessionalcobservation.cIdentifyingcunderlyingcpathologicccon
ditionscandcassistingcthecphysiciancincidentifyingcmedicalcconditionsciscnotcp
artcofcthecnursingcprocess.cDeterminingcthecpatientsc mentalcstatusc isconecpart
c ofcthec nursingc assessment,c butc itc isc notcthecprimarycpurpose.
DIF:cCognitivecLevel:cComprehensionc
REF:cdmc36cOBJ:c1c|c3cTOP:cNursingcPr
ocesscStep:cAssessment
MSC:cNCLEXc Clientc Needsc Category:c HealthcPromotionc andc Maintenance
• Whatciscthecbasisc ofcthecNANDAcIc taxonomy?
A. Functionalc healthcpatterns
B. Humancresponsec patterns
C. Basicc humanc needs
D. Pathophysiologicc needs
ANS:cB
Thec NANDAc Ic taxonomyc identifiesc humanc responsec patterns.cFunctiona
lccomponentscofchealthcpatternscareclimitedctocactivity,cfluidcvolume,cnutriti
on,cselfccare,candcsensorycperception.cBasicchumancneedsccompriseclessctha
ncmerelychealthcpatterns.c Pathophysiologiccneedsc arecnotcpartcofcthecscopec
ofcNANDAcI.
, DIF:cCognitivecLevel:cKnowledgecREF
:cpp.c37-38cOBJ:c5cTOP:
NursingcProcesscStep:cDiagnosis
MSC:cNCLEXc Clientc Needsc Category:c Physiologicalc Integrity
• Whichctaskciscincludedc incthecassessmentc stepc ofcthec nursingc process?
A. Establishingc patientc goals/outcomes
B. Implementingc thec nursingccarec planc (NCP)
C. Measuringc goal/outcomec achievement
D. Collectingc andc communicatingc data
ANS:cD
Datacareccollectedcandccommunicatedcincthecassessmentcphasecofcthecnursing
cprocess.cEstablishingcgoalsciscthecfunctioncofcplanning.
ImplementingcthecNCPciscthecfunctioncofcimplementation.cMeasuringcoutco
mecachievementciscthecfunctioncofcevaluation.
DIF:cCognitivecLevel:cComprehensionc
REF:cdmc36cOBJ:c2c|c3cTOP:cNursingcPr
ocesscStep:cAssessment
MSC:cNCLEXc Clientc Needsc Category:c HealthcPromotionc andc Maintenance
• Whichcstatementc regardingc nursingc diagnosesc isc accurate?
a. Nursingc diagnosescremaincthecsamec forcasc longcascthecdiseasec isc present.
b. Nursingc diagnosesc arec writtenctoc identifycdiseasecstates.
c. Nursingc diagnosesc describec patientc problemsc thatc nursesc treat.
d. Nursingc diagnosesc identifyccausesc relatedc tocillness.
ANS:cC
Diagnosticcstatementscidentifycproblemscacnurseciscindependentlycablectoctre
atcwithincthecscopecofcprofessionalcpractice.cNursingcdiagnosescvarycwithcth
ecchangingcconditioncofcthecpatient.cThecresponsecpatternscarecuniquectocthec
patientcandcarecnotcdiseasecspecific.cNursingcdiagnosescdescribecthecpatients
chumancresponsecpattern.
DIF:c Cognitivec Level:c Comprehension
c c cc
PRESCRIBERS 1ST EDITION BY LUO K
c c c c c
AYINGO TEST BANK | 2024 UPDATE
c c c c c
, Table of Contents
c c
Chapterc 1:cAncIntroductionctocEvidence-BasedcClinicalc PracticecGuidelines ................................................ 3
Chapterc 2:cPharmacokineticsc /Chapter3:c Pharmacodynamics...................................................................... 13
Chapter4:cPharmacogeneticsc andcPharmacogenomics ................................................................................. 25
Chapterc 5:cPharmacologyc Acrossc thecLifecSpan .......................................................................................... 30
Chapterc 6:cDrug-TherapycPrescribingcincSpecialcPopulations...................................................................... 36
Chapterc 7:cDrugcDevelopmentc andcApproval .............................................................................................. 45
Chapterc8-Chapterc10:cFoundationscofcPrescriptioncWritingcChapterc9:cResponsibleControlled-
SubstancecPrescribingcChapterc10:cAntibioticcStewardship.......................................................................... 51
Chapterc 11:c AppliedcCalculationsc forc Prescribing ....................................................................................... 58
Chapterc12-:cPromotingcAdherencecWithcPharmacotherapycII:cSystem-SpecificcandcPatient-
FocusedcPrescribingcChapterc13:cPharmacotherapycforcEar,cNose,cMouth,candThroatcConditionsc/Chapterc1
4:cPharmacotherapycforcEyecConditions....................................................................................................... 67
Chapterc 15:cPharmacotherapycforc Skinc Conditions ..................................................................................... 74
Chapterc 16:cPharmacotherapycforc Neurologicc Conditions ........................................................................... 81
Chapterc 17:cPharmacotherapycforc Cardiovascularc Conditions .................................................................... 94
Chapterc 18:cPharmacotherapycforc RespiratorycConditions ........................................................................ 106
Chapterc19:cPharmacotherapycforcGastrointestinalcConditionscandcConditionscRequiringNutritionalcSupport
................................................................................................................................................................... 117
Chapterc 20:cPharmacotherapycforc GenitourinarycConditions..................................................................... 128
Chapterc 21:cPharmacotherapycforc Renal,cAcid–Base,c Fluid,candcElectrolytecDisorders ............................ 133
Chapterc 22:cPharmacotherapycforc MusculoskeletalcandcRheumatologicc Conditions................................. 146
Chapterc 23:cTherapeuticc Applicationsc ofc Immunologyc andc Vaccines ....................................................... 158
Chapterc 24:cPharmacotherapycforc EndocrinecDisorders ............................................................................ 163
Chapterc25:cPharmacotherapycforcHematologicc Disorders ........................................................................ 174
Chapterc 26:cHematology/OncologycandcSupportivec Carecforc thecNononcologist ...................................... 190
Chapterc 27:cPharmacotherapyc RelatedctocWomen’sc Healthc Conditions .................................................... 196
Chapterc 28:cPharmacotherapycRelatedctocMen’sc Healthc Conditions.......................................................... 211
Chapterc 29:cPharmacotherapyc Relatedc tocTransgenderc Care ..................................................................... 217
Chapterc 30:cAntimicrobialcPharmacotherapy............................................................................................. 224
Chapterc 31:cAntiretroviralcPharmacotherapy ............................................................................................. 235
Chapterc32:cPsychopharmacologycandcIntegrativecHealth:cCombinedcTreatmentcofPsychiatriccandcNeuroco
gnitivec Conditions ...................................................................................................................................... 247
Chapterc 33:cPharmacotherapycforc PaincManagement ................................................................................ 257
Chapterc 34:cSubstancecUsecDisorderc III:cHealthcPromotioncandcMaintenance .......................................... 267
Chapterc 35:cOver-the-Counterc Medications............................................................................................... 283
Chapterc36:cPharmacotherapycforc Obesity ................................................................................................. 291
,Chapterc1:cAncIntroductionc tocEvidence-BasedcClinicalcPracticecGuidelines
MULTIPLEcCHOICE
• Whatciscthecprimaryc purposec ofcthec nursingc assessment?
A. Identifyingc underlyingc pathologicc conditions
B. Assistingc thec physicianc incidentifyingc medicalc conditions
C. Determiningc thec patientscmentalcstatus
D. Exploringc patientc responsesc toc healthc problems
ANS:cD
Acnursingcassessmentciscdonectocidentifycthecpatientscresponsectochealthcprob
lems.cDuringcthecnursingcassessmentcphase,caccomprehensivecinformationcba
seciscdevelopedcthroughcacphysicalcexamination,cnursingchistory,cmedicationc
history,candcprofessionalcobservation.cIdentifyingcunderlyingcpathologicccon
ditionscandcassistingcthecphysiciancincidentifyingcmedicalcconditionsciscnotcp
artcofcthecnursingcprocess.cDeterminingcthecpatientsc mentalcstatusc isconecpart
c ofcthec nursingc assessment,c butc itc isc notcthecprimarycpurpose.
DIF:cCognitivecLevel:cComprehensionc
REF:cdmc36cOBJ:c1c|c3cTOP:cNursingcPr
ocesscStep:cAssessment
MSC:cNCLEXc Clientc Needsc Category:c HealthcPromotionc andc Maintenance
• Whatciscthecbasisc ofcthecNANDAcIc taxonomy?
A. Functionalc healthcpatterns
B. Humancresponsec patterns
C. Basicc humanc needs
D. Pathophysiologicc needs
ANS:cB
Thec NANDAc Ic taxonomyc identifiesc humanc responsec patterns.cFunctiona
lccomponentscofchealthcpatternscareclimitedctocactivity,cfluidcvolume,cnutriti
on,cselfccare,candcsensorycperception.cBasicchumancneedsccompriseclessctha
ncmerelychealthcpatterns.c Pathophysiologiccneedsc arecnotcpartcofcthecscopec
ofcNANDAcI.
, DIF:cCognitivecLevel:cKnowledgecREF
:cpp.c37-38cOBJ:c5cTOP:
NursingcProcesscStep:cDiagnosis
MSC:cNCLEXc Clientc Needsc Category:c Physiologicalc Integrity
• Whichctaskciscincludedc incthecassessmentc stepc ofcthec nursingc process?
A. Establishingc patientc goals/outcomes
B. Implementingc thec nursingccarec planc (NCP)
C. Measuringc goal/outcomec achievement
D. Collectingc andc communicatingc data
ANS:cD
Datacareccollectedcandccommunicatedcincthecassessmentcphasecofcthecnursing
cprocess.cEstablishingcgoalsciscthecfunctioncofcplanning.
ImplementingcthecNCPciscthecfunctioncofcimplementation.cMeasuringcoutco
mecachievementciscthecfunctioncofcevaluation.
DIF:cCognitivecLevel:cComprehensionc
REF:cdmc36cOBJ:c2c|c3cTOP:cNursingcPr
ocesscStep:cAssessment
MSC:cNCLEXc Clientc Needsc Category:c HealthcPromotionc andc Maintenance
• Whichcstatementc regardingc nursingc diagnosesc isc accurate?
a. Nursingc diagnosescremaincthecsamec forcasc longcascthecdiseasec isc present.
b. Nursingc diagnosesc arec writtenctoc identifycdiseasecstates.
c. Nursingc diagnosesc describec patientc problemsc thatc nursesc treat.
d. Nursingc diagnosesc identifyccausesc relatedc tocillness.
ANS:cC
Diagnosticcstatementscidentifycproblemscacnurseciscindependentlycablectoctre
atcwithincthecscopecofcprofessionalcpractice.cNursingcdiagnosescvarycwithcth
ecchangingcconditioncofcthecpatient.cThecresponsecpatternscarecuniquectocthec
patientcandcarecnotcdiseasecspecific.cNursingcdiagnosescdescribecthecpatients
chumancresponsecpattern.
DIF:c Cognitivec Level:c Comprehension
